Genscript Biotech Co. (OTCMKTS:GNNSF) Short Interest Down 13.9% in August

Genscript Biotech Co. (OTCMKTS:GNNSFGet Free Report) was the target of a significant drop in short interest in the month of August. As of August 31st, there was short interest totalling 4,748,000 shares, a drop of 13.9% from the August 15th total of 5,515,500 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 47,480.0 days.

Genscript Biotech Price Performance

Shares of OTCMKTS:GNNSF remained flat at C$2.42 during trading on Tuesday. The firm has a 50-day moving average price of C$2.19 and a 200 day moving average price of C$2.36. Genscript Biotech has a 12 month low of C$1.89 and a 12 month high of C$3.53.

Genscript Biotech Company Profile

(Get Free Report)

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products, Biologics Development Services, Industrial Synthetic Biology Products, and Cell Therapy.

Recommended Stories

Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with's FREE daily email newsletter.